- Home
- NUVB vs SWIM Comparison
NUVB vs SWIM Comparison
Compare NUVB & SWIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- SWIM
- Stock Information
- Founded
- NUVB 2018
- SWIM 1956
- Country
- NUVB United States
- SWIM United States
- Employees
- NUVB N/A
- SWIM N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- SWIM Plastic Products
- Sector
- NUVB Health Care
- SWIM Industrials
- Exchange
- NUVB Nasdaq
- SWIM Nasdaq
- Market Cap
- NUVB 679.9M
- SWIM 678.4M
- IPO Year
- NUVB N/A
- SWIM 2021
- Fundamental
- Price
- NUVB $2.09
- SWIM $6.74
- Analyst Decision
- NUVB Strong Buy
- SWIM Hold
- Analyst Count
- NUVB 6
- SWIM 4
- Target Price
- NUVB $7.83
- SWIM $6.70
- AVG Volume (30 Days)
- NUVB 8.9M
- SWIM 625.9K
- Earning Date
- NUVB 08-04-2025
- SWIM 08-05-2025
- Dividend Yield
- NUVB N/A
- SWIM N/A
- EPS Growth
- NUVB N/A
- SWIM N/A
- EPS
- NUVB N/A
- SWIM N/A
- Revenue
- NUVB $10,957,000.00
- SWIM $509,311,000.00
- Revenue This Year
- NUVB $101.21
- SWIM $9.24
- Revenue Next Year
- NUVB $410.28
- SWIM $5.86
- P/E Ratio
- NUVB N/A
- SWIM N/A
- Revenue Growth
- NUVB N/A
- SWIM N/A
- 52 Week Low
- NUVB $1.54
- SWIM $2.54
- 52 Week High
- NUVB $3.97
- SWIM $8.41
- Technical
- Relative Strength Index (RSI)
- NUVB 51.54
- SWIM 67.17
- Support Level
- NUVB $1.87
- SWIM $6.33
- Resistance Level
- NUVB $2.10
- SWIM $6.62
- Average True Range (ATR)
- NUVB 0.16
- SWIM 0.32
- MACD
- NUVB 0.01
- SWIM 0.10
- Stochastic Oscillator
- NUVB 91.23
- SWIM 93.79
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About SWIM Latham Group Inc.
Latham Group Inc is a designer, manufacturer, and marketer of in-ground residential swimming pools, liners, and covers in North America, Australia, and New Zealand. It derives a majority of its revenue from the United States.